Breaking News, Collaborations & Alliances

Bora Pharmaceuticals, Corealis Pharma Partner to Provide OSD Services

Aims to simplify the OSD drug development process and provide a more scalable pathway to commercialization.

Author Image

By: Charlie Sternberg

Associate Editor

Bora Pharmaceuticals Co. Ltd., a pharmaceutical manufacturer, and Corealis Pharma Inc., an early-phase Contract Development Manufacturing Organization (CDMO), have entered into a strategic alliance to provide end-to-end services for oral solid dose (OSD) development and manufacturing. The collaboration aims to simplify the drug development process and provide a more scalable pathway to commercialization via a single continuum. Biotech and pharmaceutical innovators will now have access to both...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters